For 44 years of combined history, CarboGen and AMCIS have benefited from their prime location in Switzerland. The combined companies have flourished in a nation that delivers geographic, legislative, and economic benefits that are particularly appealing to developing pharmaceutical
companies that serve global markets. Firmly committed to their combined mission of reducing the time, cost, and risks associated with drug development, CarboGen and AMCIS routinely apply innovative science and technology for industrial advantage. Together, these leading Swiss pharmaceutical
industry suppliers serve to further science and advance therapeutic treatments that improve the human condition around the world.
No References for this article.
No Supplementary Data.
No Article Media
Document Type: Research Article
January 1, 2005
More about this publication?
International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions
CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites